Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gunn

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Trials|August 21, 2019
Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trialDavid Gunn, Ron Fried, Rabia Lalani, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2005
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 2. SARDavid Gunn, Christiana Akuche, Jeremy Baryza, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Synthesis and pharmacological characterization of a potent, orally active p38 kinase inhibitorJacques Dumas, Holia Hatoum-Mokdad, Robert N Sibley, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2007
PDE-10A inhibitors as insulin secretagoguesLouis-David Cantin, Steven Magnuson, David Gunn, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2006
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 3. Identification of lead candidateJill Wood, Cedo M Bagi, Christiana Akuche, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Trials|August 21, 2019
Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trialDavid Gunn, Ron Fried, Rabia Lalani, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2005
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 2. SARDavid Gunn, Christiana Akuche, Jeremy Baryza, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Synthesis and pharmacological characterization of a potent, orally active p38 kinase inhibitorJacques Dumas, Holia Hatoum-Mokdad, Robert N Sibley, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2007
PDE-10A inhibitors as insulin secretagoguesLouis-David Cantin, Steven Magnuson, David Gunn, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2006
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 3. Identification of lead candidateJill Wood, Cedo M Bagi, Christiana Akuche, et al.
Pageof 3